Latest stock market news videos & Morning Bell

Interviews

From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester

Bell Direct

March 20, 2026

In this episode of From the Helm, Grady is joined by Clarity Pharmaceuticals (ASX:CU6) Executive Chairperson Alan Taylor & Bell Potter Senior Analyst John Hester, for a deep dive into their next-generation radiopharmaceutical technology for both early-stage cancer diagnosis and treatment.

Market Wraps

Weekly Wrap 17 April

Bell Direct

April 17, 2026

Interviews

From the helm: Centaurus Metals (ASX:CTM), CEO & MD, Darren Gordon

Bell Direct

April 2, 2026

Interviews

From the helm: Oneview Healthcare (ASX:ONE), CEO, James Fitter

Bell Direct

April 2, 2026

Interviews

From the helm: Titomic Ltd, CFO, Geoff Hollis

Bell Direct

April 1, 2026

Interviews

From the helm: Artrya Limited (ASX:AYA): John Konstantopoulos, CEO & Co-Founder

Bell Direct

April 1, 2026

Interviews

From the helm: Bell Financial Group (ASX:BFG): Arnie Selvarajah, Group Co-CEO

Bell Direct

April 1, 2026

Market Wraps

Navigating geopolitical turbulence:The strategic case for defence technology

Bell Direct

March 31, 2026

Market Wraps

Weekly Wrap 27 March

Bell Direct

March 27, 2026

Interviews

From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.

Bell Direct

March 20, 2026

Interviews

From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

Bell Direct

March 20, 2026

Interviews

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Bell Direct

March 20, 2026

Interviews

From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.

Bell Direct

March 20, 2026